Asset Details
Do you wish to reserve the book?
Intranasal Administration of the Growth-Compromised HSV-2 Vector ΔRR Prevents Kainate-Induced Seizures and Neuronal Loss in Rats and Mice
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Intranasal Administration of the Growth-Compromised HSV-2 Vector ΔRR Prevents Kainate-Induced Seizures and Neuronal Loss in Rats and Mice
Do you wish to request the book?
Intranasal Administration of the Growth-Compromised HSV-2 Vector ΔRR Prevents Kainate-Induced Seizures and Neuronal Loss in Rats and Mice
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Intranasal Administration of the Growth-Compromised HSV-2 Vector ΔRR Prevents Kainate-Induced Seizures and Neuronal Loss in Rats and Mice
2006
Overview
Identification of targets and delivery platforms for gene therapy of neurodegenerative disorders is a clinical challenge. We describe a novel paradigm in which the neuroprotective gene is the herpes simplex virus type 2 (HSV-2) antiapoptotic gene ICP10PK and the vector is the growth-compromised HSV-2 mutant ΔRR. ΔRR is delivered intranasally. It is not toxic in rats and mice. ICP10PK is expressed in the hippocampus of the ΔRR-treated animals for at least 42 days in the absence of virus replication and late virus gene expression. Its expression is regulated by an AP-1 amplification loop. Intranasally delivered ΔRR prevents kainic acid-induced seizures, neuronal loss, and inflammation, in both rats and mice. The data suggest that ΔRR is a promising therapeutic platform for neurodegenerative diseases.
